Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer

M. Shimada; J. Kigawa; N. Terakawa; A. Yoshizaki; T. Shoji; M. Suzuki; M. Hatae; H. Tsuda; M. Ohwada; T. Sugiyama

doi:10.1111/j.1525-1438.2007.00801.x

Article info

ORIGINAL ARTICLE

Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer

Authors

M. Shimada Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Japan; PubMed articles Google scholar articles
J. Kigawa Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Japan; PubMed articles Google scholar articles
N. Terakawa Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Japan; PubMed articles Google scholar articles
A. Yoshizaki Department of Obstetrics and Gynecology, Iwate Medical University, Morioka, Japan; PubMed articles Google scholar articles
T. Shoji Department of Obstetrics and Gynecology, Iwate Medical University, Morioka, Japan; PubMed articles Google scholar articles
M. Suzuki Department of Obstetrics and Gynecology, Jichi Medical School, Utsunomiya, Japan; PubMed articles Google scholar articles
M. Hatae Department of Obstetrics and Gynecology, Kagoshima City Hospital, Kagoshima, Japan PubMed articles Google scholar articles
H. Tsuda Department of Obstetrics and Gynecology, Osaka City General Hospital, Osaka, Japan PubMed articles Google scholar articles
M. Ohwada Department of Obstetrics and Gynecology, Jichi Medical School, Utsunomiya, Japan; PubMed articles Google scholar articles
T. Sugiyama Department of Obstetrics and Gynecology, Iwate Medical University, Morioka, Japan; PubMed articles Google scholar articles

Address correspondence and reprint requests to: Toru Sugiyama, MD, PhD, Department of Obstetrics and Gynecology, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate Prefecture 020-8505, Japan. Email: sugiyama{at}iwate-med.ac.jp

Citation

Shimada M, Kigawa J, Terakawa N, et al

Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer

International Journal of Gynecologic Cancer 2007;17:210-214.

Publication history

First published January 1, 2007.

Online issue publication

January 01, 2007

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password